FSSNX | IJSAX | FSSNX / IJSAX | |
Total Expense Ratio | 0.03 | 1.48 | 2% |
Annual Report Gross Expense Ratio | 0.03 | 1.48 | 2% |
Fund Existence | 14 years | 21 years | - |
Gain YTD | 3.468 | -14.926 | -23% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 25.9B | 303M | 8,548% |
Annual Yield % from dividends | 0.90 | 0.03 | 2,642% |
Returns for 1 year | 8.73 | -12.23 | -71% |
Returns for 3 years | 18.75 | -11.61 | -161% |
Returns for 5 years | 51.48 | -13.12 | -392% |
Returns for 10 years | 85.72 | -31.86 | -269% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
JNGLX | 68.49 | 0.92 | +1.36% |
Janus Henderson Global Life Sciences D | |||
JACLX | 18.32 | 0.08 | +0.44% |
JHancock Mid Cap Growth C | |||
VALLX | 44.81 | 0.09 | +0.20% |
Value Line Larger Companies Focused Inv | |||
FFXFX | 90.12 | -0.36 | -0.40% |
American Funds Fundamental Invs 529-F-2 | |||
QSMNX | 18.43 | -0.12 | -0.65% |
AQR Small Cap Multi-Style N |